|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION
EXTRACTED FROM THE BALANCE SHEETS AND STATEMENTS OF OPERATIONS OF
BIOLABS, INC. FOR THE QUARTER ENDED SEPTEMBER 30, 2000, AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 2,208,573
<SECURITIES> 0
<RECEIVABLES> 19,643
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 2,246,761
<PP&E> 24,992
<DEPRECIATION> (10,485)
<TOTAL-ASSETS> 9,566,219
<CURRENT-LIABILITIES> 3,061,007
<BONDS> 0
0
141
<COMMON> 11,019,514
<OTHER-SE> (4,514,443)
<TOTAL-LIABILITY-AND-EQUITY> 9,566,219
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 1,468,576
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 185,334
<INCOME-PRETAX> (1,653,910)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,653,910)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,653,910)
<EPS-BASIC> (0.19)
<EPS-DILUTED> (0.19)
</TABLE>
|
|